Use of sodium‐glucose cotransporter‐2 inhibitors in France: Analysis of French nationwide health insurance database
Sibylle de Germay,
Elodie Pambrun,
Antoine Pariente
et al.
Abstract:AimSodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) have been commercialized in France for type 2 diabetes since April 2020 and later for heart and renal diseases. Given the recent developments in treating diabetes and the widening of SGLT‐2i indications, we aimed to study changes in the use of glucose‐lowering drugs in France and to characterize SGLT‐2i new users.MethodsWe performed a nationwide utilization study using the French health insurance database. Trends in incidence and prevalence of glucose‐lowe… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.